Cognizin Ingredient Shown to Improve Focus, Concentration and Memory

26 Jan 2011 --- A six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., was designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

1/26/2011 --- Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, presented new scientific data on Kyowa Hakko's branded brain health ingredient Cognizin at the SupplySide Science Tour held January 24, 2011, in Irvine, Calif. She highlighted results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

On the first day of testing, 16 healthy subjects aged 40 - 60 years underwent functional Magnetic Resonance Imaging (fMRI) while completing both the Stroop task, which is designed to measure attention and reaction time, and the Morris Water Maze task, which examines spatial memory. Subjects were then given a daily oral dose of either 500 or 2000 mg of Cognizin for six weeks before a second imaging protocol was conducted.

After completion of the second fMRI imaging test, increased activation was seen during completion of the Stroop interference task. This was accompanied by improved accuracy in generating correct responses. 

These results indicated that use of Cognizin resulted in a better, more accurate performance, accompanied by increased brain metabolism. 
Increased activation was seen during completion of the second Water Maze test as well. This was accompanied by increased time spent in the correct quadrant. These results indicated that use of Cognizin resulted in better spatial memory retrieval, in addition to increased brain metabolism. Results were nearly identical for individuals receiving 500 mg and 2000 mg of Cognizin, confirming that statistically significant improvements in attention, focus, memory and recall can be achieved at dosing levels of 500 mg.

"Neuroimaging data demonstrated increased regional brain activation, which was related to increased concentration, greater ability to focus and improved accuracy on cognitive tasks after subjects received Cognizin," noted Dr. Yurgelun-Todd. "Greater performance on a spatial memory task was also observed."

Cognizin Citicoline is a natural, water-soluble brain health ingredient, and is a well-established part of the cognitive health category. Vast research indicates this safe and effective branded compound helps protect neural tissue from free radical damage. It also supports brain performance by enhancing metabolism and healthy activity. Unlike other single-action ingredients for brain health, Cognizin is multi-functional. It has shown to benefit individuals affected by memory loss, mood/behavioral disorders, mild cognitive impairment and certain vision disorders.

Related Articles

Health & Nutrition News

Promising Link Found Between Probiotics and Chronic Inflammatory Disease

30 Jul 2015 --- Probiotics may improve the behavioral symptoms of chronic inflammatory diseases by altering communication between the immune system and the brain, according to an animal study published July 29 in the Journal of Neuroscience. 

Health & Nutrition News

Study: Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment

29 Jul 2015 --- A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di SanitĂ  (ISS), Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.

Health & Nutrition News

Research: High Blood Sugar and Diabetes Have a Negative Effect on Cognitive Skills

16 Jul 2015 --- Participants with type two diabetes in a two-year study experienced negative changes in their ability to regulate blood flow to the brain, which was then linked to lower scores on cognition skills tests and their capacity to perform daily activities. The study, published in the Neurology journal, highlights the importance of blood sugar control in maintaining cognitive function in those with type 2 diabetes.

Health & Nutrition News

Research Shows Long-Term Effects of Type 2 Diabetes on the Brain

09 Jul 2015 --- Over a period of two years, people with type 2 diabetes experienced negative changes in their cognitive skills and ability to perform their daily activities, according to a new study published in Neurology, the medical journal of the American Academy of Neurology. 

More Articles
URL : http://www.nutritioninsight.com:80/news/Cognizin-Ingredient-Shown-to-Improve-Focus-Concentration-and-Memory.html